Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial Agents and Chemotherapy 2009-12, Vol.53 (12), p.5275-5278
Hauptverfasser:	LOCKE, Jeffrey B, HILGERS, Mark, SHAW, Karen Joy
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetamides - metabolism Acetamides - pharmacology Antibiotics. Antiinfectious agents. Antiparasitic agents Binding Sites - genetics Binding Sites - physiology Biological and medical sciences Drug Resistance, Bacterial Drug Resistance, Bacterial - genetics Drug Resistance, Bacterial - physiology Linezolid Mechanisms of Resistance Medical sciences Mutation Mutation - genetics Oxazolidinones Oxazolidinones - metabolism Oxazolidinones - pharmacology Pharmacology. Drug treatments Protein Structure, Secondary Ribosomal Proteins Ribosomal Proteins - chemistry Ribosomal Proteins - genetics RNA, Ribosomal, 23S - genetics Staphylococcal Infections Staphylococcal Infections - microbiology Staphylococcus Staphylococcus - drug effects Staphylococcus - genetics Staphylococcus aureus Staphylococcus aureus - drug effects Staphylococcus aureus - genetics Staphylococcus epidermidis Tetrazoles - metabolism Tetrazoles - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!